More good safety results as Prescient Therapeutics continues cancer treatment tests
Australian biotech company Prescient Therapeutics has successfully finished a round of safety testing on its...
Australian biotech company Prescient Therapeutics has successfully finished a round of safety testing on its...
Prescient Therapeutics (PTX) is progressing the trial of its cancer-blocking drug PTX100 following successful results...
The US Food and Drug Administration has assigned a fast track designation to a new...
Shares in biotech company, Prescient Therapeutics, have proved buoyant this week after initial immunogenicity testing...
In an upbeat development, Prescient Therapeutics Limited (ASX:PTX) has announced outstanding findings from in silico...
Shares in Prescient Therapeutics Ltd (ASX: PTX) have surged to fresh heights today on the back of news...
Prescient Therapeutics (PTX) says recent results from testing show its entire platform has been substantially...
The results significantly de-risk the project as PTX continues development of its OmniCAR platform. As...
Tragedy struck the CAR-T space this month with a US company halting a trial of...
In a milestone development regarding its innovative CAR-T cancer therapy programs, Prescient Therapeutics Limited (ASX:PTX) has announced...
This investor centre was built by Reach Markets
©2025 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.